Ident. | Authors (with country if any) | Title |
---|
000013 (2021) |
Sujeet Jha [Inde] ; Nitish Batra [Inde] ; Samreen Siddiqui [Inde] ; Ashutosh Yadav [Inde] ; Archa Misra [Inde] ; Menka Loomba [Inde] ; Sumeet Sethi [Inde] ; Swati Waghdhare [Inde] | HCQ prophylaxis in COVID-19 did not show any QTc prolongation in Healthcare workers. |
000020 (2021) |
Fabio Cruciani [Italie] ; Laura Amato [Italie] ; Franco De Crescenzo ; Zuzana Mitrova [Italie] ; Rosella Saulle [Italie] ; Simona Vecchi [Italie] ; Marina Davoli [Italie] | [The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.] |
000029 (2021) |
Maurizio Koch | [2020: Evidence-Based Medicine odyssey. The fall and rise of evidence-based medicine in the year of coronavirus.] |
000054 (2021) |
Iván J. Nú Ez-Gil [Espagne] ; Antonio Fernández-Ortiz [Espagne] ; Charbel Maroud Eid [Espagne] ; Jia Huang [République populaire de Chine] ; Rodolfo Romero [Espagne] ; Victor Manuel Becerra-Mu Oz [Espagne] ; Aitor Uribarri [Espagne] ; Gisela Feltes ; Daniela Trabatoni [Italie] ; Inmaculada Fernandez-Rozas [Espagne] ; Maria C. Viana-Llamas [Espagne] ; Martino Pepe ; Enrico Cerrato [Italie] ; Maurizio Bertaina [Italie] ; Thamar Capel Astrua [Espagne] ; Emilio Alfonso [Cuba] ; Alex F. Castro-Mejía ; Sergio Raposeiras-Roubin ; Fabrizio D'Ascenzo ; Carolina Espejo Paeres [Espagne] ; Jaime Signes-Costa [Espagne] ; Alfredo Bardaji ; Cristina Fernandez-Pérez [Espagne] ; Francisco Marin [Espagne] ; Oscar Fabregat-Andres [Espagne] ; Ibrahim Akin [Allemagne] ; Vicente Estrada [Espagne] ; Carlos Macaya [Espagne] | Underlying heart diseases and acute COVID-19 outcomes. |
000078 (2021) |
Ales Janda [Allemagne] ; Catharina Schuetz [Allemagne] ; Scott Canna [États-Unis] ; Mark Gorelik [États-Unis] ; Maximilian Heeg [Allemagne] ; Kirsten Minden [Allemagne] ; Claas Hinze [Allemagne] ; Ansgar Schulz [Allemagne] ; Klaus-Michael Debatin [Allemagne] ; Christian M. Hedrich [Royaume-Uni] ; Fabian Speth [Allemagne] | Therapeutic approaches to pediatric COVID-19: an online survey of pediatric rheumatologists. |
000088 (2021) |
Minas Theodore Coroneo [Australie] | The eye as the discrete but defensible portal of coronavirus infection. |
000093 (2021) |
Derek Shyr [États-Unis] ; Yu Shyr [États-Unis] | The design and analysis of non-randomized studies: a case study of off-label use of hydroxychloroquine in the COVID-19 pandemic. |
000102 (2021) |
Saeed Ur Rashid Nazir ; Taha Nazir ; Misbah Sultana ; Rahat Shamim ; Humayun Riaz ; Safia Sultana Munir ; Ruqaiya Rasheed Kayani ; Saba Manzoor ; Azharul Islam | The Potentially Recommended Pharmacotherapy for COVID-19. |
000104 (2021) |
Farah Daou [Liban] ; Gretta Abou-Sleymane [Liban] ; Danielle A. Badro [Liban] ; Nagham Khanafer [France] ; Mansour Tobaiqy [Arabie saoudite] ; Achraf Al Faraj [Liban] | The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19. |
000135 (2021) |
Baptiste Maille [France] ; Marie Wilkin [France] ; Matthieu Million [France] ; Noémie Rességuier [France] ; Frédéric Franceschi [France] ; Linda Koutbi-Franceschi [France] ; Jérôme Hourdain [France] ; Elisa Martinez [France] ; Maxime Zabern [France] ; Christophe Gardella [France] ; Hervé Tissot-Dupont [France] ; Jagmeet P. Singh [États-Unis] ; Jean-Claude Deharo [France] ; Laurent Fiorina [France] | Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT-logs study. |
000142 (2021) |
Mohamed S. Mohamed [Suède] ; Thiago C. Moulin [Suède] ; Helgi B. Schiöth [Suède, Russie] | Sex differences in COVID-19: the role of androgens in disease severity and progression. |
000153 (2021) |
Kavita Manchanda [Inde] ; Jasbir Singh [Inde] ; Ranjeev Bhagat [Inde] ; Ilmjot Kaur Tiwana [Inde] ; Harmanjit Singh [Inde] | Safety of pharmacological options for the management of COVID-19 in pregnant women: An Indian perspective. |
000166 (2021) |
Giulia Fiscon [Italie] ; Federica Conte [Italie] ; Lorenzo Farina [Italie] ; Paola Paci [Italie] | SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19. |
000167 (2021) |
Masoomeh Sofian [Iran] ; Ali Akbar Velayati [Iran] ; Mohammad Banifazl [Iran] ; Fatemeh Fotouhi [Iran] ; Mona Sadat Larijani [Iran] ; Neda Afzali [Iran] ; Amitis Ramezani [Iran] | SARS-CoV‑2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms. |
000181 (2021) |
Pravindra Kumar [Inde] ; Ashok Kumar Sah [Inde] ; Greesham Tripathi [Inde] ; Anjali Kashyap [Inde] ; Avantika Tripathi [Inde] ; Rashmi Rao [Inde] ; Prabhu C. Mishra [Inde] ; Koustav Mallick [Inde] ; Amjad Husain [Inde] ; Manoj Kumar Kashyap [Inde] | Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19. |
000182 (2021) |
Philippe Guilpain [France] ; Clément Le Bihan [France] ; Vincent Foulongne [France] ; Patrice Taourel [France] ; Nathalie Pansu [France] ; Alexandre Thibault Jacques Maria [France] ; Boris Jung [France] ; Romaric Larcher [France] ; Kada Klouche [France] ; Vincent Le Moing [France] | Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia. |
000187 (2021) |
Takahisa Mikami [États-Unis] ; Hirotaka Miyashita [États-Unis] ; Takayuki Yamada [États-Unis] ; Matthew Harrington [États-Unis] ; Daniel Steinberg [États-Unis] ; Andrew Dunn [États-Unis] ; Evan Siau [États-Unis] | Risk Factors for Mortality in Patients with COVID-19 in New York City. |
000226 (2021) |
Minh Patrick Lê [France] ; Nathan Peiffer-Smadja [France] ; Jeremie Guedj [France] ; Nadège Neant [France] ; France Mentré [France] ; Florence Ader [France] ; Yazdan Yazdanpanah [France] ; Gilles Peytavin [France] | Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response. |
000258 (2021) |
Gagan Kumar [États-Unis] ; Alex Adams [États-Unis] ; Martin Hererra [États-Unis] ; Erine Raybon Rojas [États-Unis] ; Vartika Singh [Inde] ; Ankit Sakhuja [États-Unis] ; Mark Meersman [États-Unis] ; Drew Dalton [États-Unis] ; Shravan Kethireddy [États-Unis] ; Rahul Nanchal [États-Unis] ; Achuta Kumar Guddati [États-Unis] | Predictors and outcomes of healthcare-associated infections in COVID-19 patients. |
000265 (2021) |
Gayathri Baburaj [Inde] ; Levin Thomas [Inde] ; Mahadev Rao [Inde] | Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies. |
000268 (2021) |
Sinan Karde [Turquie] ; Ali Suat Kuzu [Turquie] ; Haig Pakhchanian [États-Unis] ; Rahul Raiker [États-Unis] ; Mine Karagülle [Turquie] | Population-level interest in anti-rheumatic drugs in the COVID-19 era: insights from Google Trends. |
000288 (2021) |
David R. Ha [États-Unis] ; Jamie Kuo [États-Unis] ; Phyo S. Aung [États-Unis] ; Tiffany Chang [États-Unis] ; Lana G. Witt [États-Unis] ; William Alegria [États-Unis] ; Amy Chang [États-Unis] ; Lina Meng [États-Unis] ; Stanley P. Deresinski [États-Unis] | Outpatient hydroxychloroquine prescribing at a large academic health system during the COVID-19 pandemic. |
000294 (2021) |
Sanjay Kumar Mishra [Inde] ; Timir Tripathi [Inde] | One year update on the COVID-19 pandemic: Where are we now? |
000299 (2021) |
Marko Boban [Croatie] | Novel coronavirus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments. |
000318 (2021) |
Nathaniel J. Rhodes [États-Unis] ; Atheer Dairem [États-Unis] ; William J. Moore [États-Unis] ; Anooj Shah [États-Unis] ; Michael J. Postelnick [États-Unis] ; Melissa E. Badowski [États-Unis] ; Sarah M. Michienzi [États-Unis] ; Jaime L. Borkowski [États-Unis] ; Radhika S. Polisetty [États-Unis] ; Karen Fong ; Emily S. Spivak ; James R. Beardsley [États-Unis] ; Cory M. Hale [États-Unis] ; Andrea M. Pallotta [États-Unis] ; Pavithra Srinivas [États-Unis] ; Lucas T. Schulz [États-Unis] | Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States. |
000326 (2021) |
C N Prashantha [Inde] ; K. Gouthami [Inde] ; L. Lavanya [Inde] ; Sivaramireddy Bhavanam [Inde] ; Ajay Jakhar [Inde] ; R G Shakthiraju [Inde] ; V. Suraj [Inde] ; K V Sahana [Inde] ; H S Sujana [Inde] ; N M Guruprasad [Inde] ; R. Ramachandra [Inde] | Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus. |
000345 (2021) |
Claudia Musial [Pologne] ; Magdalena Gorska-Ponikowska [Pologne] | Medical progress: Stem cells as a new therapeutic strategy for COVID-19. |
000347 (2021) |
Benjamin Coiffard [France] ; Philipp M. Lepper [Allemagne] ; Eloi Prud'Homme [France] ; Florence Daviet [France] ; Nadim Cassir [France] ; Heinrike Wilkens [Allemagne] ; Sami Hraiech [France] ; Frank Langer [Allemagne] ; Pascal A. Thomas [France] ; Martine Reynaud-Gaubert [France] ; Robert Bals [Allemagne] ; Hans-Joachim Sch Fers [Allemagne] ; Laurent Papazian [France] ; Frederik Seiler [Allemagne] | Management of lung transplantation in the COVID-19 era-An international survey. |
000350 (2021) |
Shih-Chieh Shao ; Edward Chia-Cheng Lai ; Yi-Hua Chen ; Yuk-Ying Chan ; Hui-Yu Chen | Management of Irrational Self-Purchase of Hydroxychloroquine During the COVID-19 Pandemic: Experiences From the Largest Healthcare System in Taiwan. |
000357 (2021) |
Theodor Voiosu [Roumanie] ; Andrei Voiosu [Roumanie] | Lessons from a pandemic: Do not force your patients into the bed of Procrustes! |
000360 (2021) |
Sergey Moiseev [Oman] ; Sergey Avdeev [Russie] ; Michail Brovko [Russie] ; Pavel Novikov [Russie] ; Victor Fomin [Russie] | Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)? |
000377 (2021) |
Mohsen Farrokhpour [Iran] ; Nader Rezaie [Iran] ; Najmeh Moradi [Iran] ; Fatemeh Ghaffari Rad [Iran] ; Shirin Izadi [Iran] ; Mehdi Azimi [Iran] ; Farhad Zamani [Iran] ; Shahrokh Izadi [Iran] ; Mitra Ranjbar [Iran] ; Mahin Jamshidi Makiani [Iran] ; Azadeh Laali [Iran] ; Maryam Roham [Iran] ; Mahdi Yadollahzadeh [Iran] | Infliximab and Intravenous Gammaglobulin in Hospitalized Severe COVID-19 Patients in Intensive Care Unit. |
000386 (2021) |
P R Chai [États-Unis] ; E G Ferro [États-Unis] ; J M Kirshenbaum [États-Unis] ; B D Hayes [États-Unis] ; S E Culbreth [États-Unis] ; E W Boyer [États-Unis] ; T B Erickson [États-Unis] | In Reply to "Hydroxychloroquine Overdose: What Are the Exact Roles of Diazepam and Potassium Infusion?" |
000387 (2021) |
Manish Rathi [Inde] ; Parmeshar Singh [Inde] ; Hayath Peta Bi [Inde] ; Archana Shivanna [Inde] ; Chengappa Kavadichanda [Inde] ; Saumya Ranjan Tripathy ; Janani Parthasarathy [Inde] ; Sneha Tota [Inde] ; Supriya Maurya [Inde] ; Vishnupriya Vijayalekshmi [Inde] ; D. Bhavani [Inde] ; Avinash Jain [Inde] ; Ranjan Gupta [Inde] ; Debashish Danda [Inde] ; Liza Rajasekhar [Inde] ; Vir Singh Negi [Inde] ; Vineeta Shobha [Inde] ; Bidyut Das ; Amita Aggarwal [Inde] | Impact of the COVID-19 pandemic on patients with systemic lupus erythematosus: Observations from an Indian inception cohort. |
000392 (2021) |
Esam Abualfadl [Égypte] ; Faten Ismail [Égypte] ; Rawhya R El Shereef [Égypte] ; Eman Hassan [Égypte] ; Samar Tharwat [Égypte] ; Eman F. Mohamed [Égypte] ; Essam A. Abda [Égypte] ; Ahmed R. Radwan [Égypte] ; Rasha M. Fawzy [Égypte] ; Abdel Hafeez Moshrif [Égypte] ; Rasha Abdel Noor [Égypte] ; Soha Senara [Égypte] ; Mervat I Abd Elazim [Égypte] ; Nouran M. Abaza [Égypte] ; Hala A. Raafat [Égypte] ; Iman I. El-Gazzar [Égypte] ; Dina H. El-Hammady [Égypte] ; Nevin Hammam [Égypte, États-Unis] ; Tamer A. Gheita [Égypte] ; Reem El-Mallah [Égypte] | Impact of COVID-19 pandemic on rheumatoid arthritis from a Multi-Centre patient-reported questionnaire survey: influence of gender, rural-urban gap and north-south gradient. |
000398 (2021) |
Pankaj Bansal [États-Unis] ; Amandeep Goyal [États-Unis] ; Austin Cusick [États-Unis] ; Shubham Lahan [Inde] ; Harpal S. Dhaliwal [Inde] ; Poonam Bhyan [États-Unis] ; Pradnya Brijmohan Bhattad [États-Unis] ; Fawad Aslam [États-Unis] ; Sagar Ranka [États-Unis] ; Tarun Dalia [États-Unis] ; Lovely Chhabra [États-Unis] ; Devang Sanghavi [États-Unis] ; Bhavin Sonani [États-Unis] ; John M. Davis [États-Unis] | Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019. |
000441 (2021) |
Asokan Devarajan [États-Unis] ; Marmar Vaseghi [États-Unis] | Hydroxychloroquine can potentially interfere with immune function in COVID-19 patients: Mechanisms and insights. |
000443 (2021) |
Lionel Carbillon [France] ; Amelie Benbara [France] ; Jeremy Boujenah [France] | Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment. |
000446 (2021) |
Massimo Nicol [Italie] ; Lorenzo Ferro Desideri [Italie] ; Matteo Bassetti [Italie] ; Carlo Enrico Traverso [Italie] | Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak. |
000453 (2021) |
Bruno Mégarbane [France] ; Azzurra Schicchi [Italie] | Hydroxychloroquine Overdose: What Are the Exact Roles of Diazepam and Potassium Infusion? |
000461 (2021) |
Bernardo Pérez-González [Mexique] ; Freyris C. Thomas-Lora [Mexique] ; Irma Hoyo [Mexique] ; Nayelli C. Flores-García [Mexique] ; Erika F. Rodríguez-Aguilar [Espagne] ; Víctor M. Páez-Zayas [Mexique] ; Ernesto Márquez-Guillén [Mexique] ; Víctor Visag-Castillo [Mexique] ; Ignacio García-Juárez [Mexique] ; Alan G. Contreras [Mexique] | Hepatic transplant during SARS-CoV-2 (COVID-19) pandemic. A literature review. |
000462 (2021) |
Alberto M. Borobia [Espagne] ; Irene García-García [Espagne] ; Lucía Díaz-García [Espagne] ; Amelia Rodríguez-Mariblanca [Espagne] ; Lucía Martínez De Soto [Espagne] ; Jaime Monserrat Villatoro [Espagne] ; Enrique Seco Meseguer [Espagne] ; Juan J. González [Espagne] ; Jesús Frías Iniesta [Espagne] ; Elena Ramírez García [Espagne] ; Jose Ram N Arribas [Espagne] ; Antonio J. Carcas-Sansuán [Espagne] | Health Care Workers' Reasons for Choosing Between Two Different COVID-19 Prophylaxis Trials in an Acute Pandemic Context: Single-Center Questionnaire Study. |
000475 (2021) |
S. Rakedzon [Israël] ; A. Neuberger [Israël] ; A J Domb [Israël] ; N. Petersiel [Israël] ; E. Schwartz [Israël] | From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2? |
000481 (2021) |
Razieh Morad [Afrique du Sud] ; Mahmood Akbari [Afrique du Sud] ; Parham Rezaee [Iran] ; Amin Koochaki [Iran] ; Malik Maaza [Afrique du Sud] ; Zahra Jamshidi [Iran] | First principle simulation of coated hydroxychloroquine on Ag, Au and Pt nanoparticles. |
000491 (2021) |
Gaurav Joshi [Inde] ; Shikha Thakur [Inde] ; Mayank [Inde] ; Ramarao Poduri [Inde] | Exploring insights of hydroxychloroquine, a controversial drug in Covid-19: An update. |
000517 (2021) |
Emanuele Pontali [Italie] ; Stefano Volpi [Italie] ; Alessio Signori [Italie] ; Giancarlo Antonucci [Italie] ; Marco Castellaneta [Italie] ; Davide Buzzi [Italie] ; Amedeo Montale [Italie] ; Marta Bustaffa [Italie] ; Alessia Angelelli [Italie] ; Roberta Caorsi [Italie] ; Elisa Giambruno [Italie] ; Nicoletta Bobbio [Italie] ; Marcello Feasi [Italie] ; Ilaria Gueli [Italie] ; Francesca Tricerri [Italie] ; Francesca Calautti [Italie] ; Elio Castagnola [Italie] ; Andrea Moscatelli [Italie] ; Gian Andrea Rollandi [Italie] ; Angelo Ravelli [Italie] ; Giovanni Cassola [Italie] ; Maria Pia Sormani [Italie] ; Marco Gattorno [Italie] | Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia. |
000520 (2021) |
Falasca Katia [Italie] ; Di Penta Myriam [Italie] ; Claudio Ucciferri [Italie] ; Antonio Auricchio [Italie] ; Marta Di Nicola [Italie] ; Michele Marchioni [Italie] ; Celletti Eleonora [Italie] ; Sabatini Emanuela [Italie] ; Francesco Cipollone [Italie] ; Jacopo Vecchiet [Italie] | Efficacy of canakinumab in mild or severe COVID-19 pneumonia. |
000589 (2021) |
Matthew P. Fox ; Lucy D'Agostino Mcgowan ; Bryan D. James ; Justin Lessler ; Shruti H. Mehta ; Eleanor J. Murray | Concerns About the Special Article on Hydroxychloroquine and Azithromycin in High-Risk Outpatients With COVID-19. |
000595 (2021) |
Figen Sarigul Yildirim [Turquie] ; Murat Sayan [Turquie] ; Tamer Sanlidag [Turquie] ; Berna Uzun [Turquie] ; Dilber Uzun Ozsahin [Turquie] ; Ilker Ozsahin [Turquie] | Comparative Evaluation of the Treatment of COVID-19 with Multicriteria Decision-Making Techniques. |
000600 (2021) |
Carlo Gagliotti [Italie] ; Rossella Buttazzi [Italie] ; Enrico Ricchizzi [Italie] ; Simona Di Mario [Italie] ; Sara Tedeschi [Italie] ; Maria Luisa Moro [Italie] | Community use of antibiotics during the COVID-19 lockdown. |
000602 (2021) |
Bruno Mégarbane [France] ; Jean-Michel Scherrmann [France] | Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial. |